Cost of care – alk

Cost of care

Time to REACT in AIT

5 Key results
Results from REACT, the first major study within the REWEAL programme. It's time to REACT in AIT.
5 Key results

Potential new AIT benefits
Beyond relevant outcomes in allergic rhinitis (AR) and asthma, the REACT study also revealed potential new findings related to allergy immunotherapy (AIT), such as reduced risk of pneumonia and hospitalisations. Read more here.
Potential new benefits

Understanding allergy immunotherapy utilisation in the United States
AIT is available to many Americans suffering from AR, but before this study, only limited evidence existed on both the burden of disease in patients receiving AIT, as well as the economic patterns behind the initiation of AIT.
AIT in the US